Melissa West

PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models

Helen Y. Zou, Luc Friboulet, David P. Kodack et al. · Cancer Cell · 2015 · 463 citations · Full text

Medicine, Oncology, Pharmacology +14

PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations

Helen Y. Zou, Qiuhua Li, Lars D. Engstrom et al. · Proceedings of the National Academy of Sciences · 2015 · 269 citations · Full text

Medicine, Oncology, Pharmacology +15

RECOGNIZING DINOFLAGELLATE SPECIES USING ITS rDNA SEQUENCES¹

R. Wayne Litaker, Mark W. Vandersea, Steven R. Kibler et al. · Journal of Phycology · 2007 · 188 citations

Life Sciences, Biology, Marine Biology +13

Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots.

James X. Chen, Yi Zheng, Melissa West et al. · PubMed · 1998 · 148 citations

Medicine, Molecular Biology, Oncology +17

Method for gene replacement in Pseudomonas aeruginosa used in construction of recA mutants: recA-independent instability of alginate production

Dennis E. Ohman, Melissa West, JoAnne L. Flynn et al. · Journal of Bacteriology · 1985 · 55 citations · Full text

Life Sciences, Genetics, Microbiology +17